NEO (NeoGenomics) EV-to-EBIT : -14.51 (As of Jul. 22, 2025)

NeoGenomics EV-to-EBIT Chart

NeoGenomics Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					-846.53	-631.94	-8.87	-25.03	-31.47

NeoGenomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															-26.44	-25.96	-28.81	-31.47	-20.32

Competitive Comparison of NeoGenomics's EV-to-EBIT

For the Diagnostics & Research subindustry, NeoGenomics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoGenomics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NeoGenomics's EV-to-EBIT falls into.

NeoGenomics EV-to-EBIT Calculation

NeoGenomics's EV-to-EBIT for today is calculated as:

NeoGenomics's current Enterprise Value is $1,045.9 Mil.
NeoGenomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-72.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics  (NAS:NEO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

NeoGenomics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

NeoGenomics's Enterprise Value for the quarter that ended in Mar. 2025 was $1,464.8 Mil.
NeoGenomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-72.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of NeoGenomics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoGenomics Business Description